Addition to Scientific Advisory Board

The “New” Prostate Cancer InfoLink is pleased to announce that Andrew Vickers, PhD, a specialist in biostatistics and research methodology, has accepted an invitation to join the Scientific Advisory Board of The “New” Prostate Cancer InfoLink.

Dr. Vickers works at Memorial Sloan-Kettering Cancer Center in New York. He has already been recognized within the prostate cancer research community for his determination to bring new rigor to studies intended to demonstrate the clinical value of prostate cancer markers such as PSA velocity and others. Such studies are certainly in the best long-term interests of patients, and we look forward to seeing the fruits of his research over the next few years.

For more information about Dr. Vickers, please see his brief bio on our Scientific Advisory Board web page or a more detailed biography on his faculty page on the Memorial Sloan-Kettering Cancer Center web site.

%d bloggers like this: